Haney et al. harnessed EV therapy for the intranasal delivery of catalase to the brain, reducing brain oxidative stress and inflammation and improving neuronal survival in a mouse model of Parkinson's disease 145. The gene discussed is CAT; the disease is Parkinson disease.